A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer

Nicholas Zaorsky, Kosj Yamoah, Madhukar L. Thakur, Edouard J. Trabulsi, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Approximately a third of men with localized prostate cancer who are treated with external beam radiation therapy (EBRT) or radical prostatectomy (RP) develop biochemical failure (BF). Presumably, BF will progress to distant metastasis and prostate cancer-specific mortality in some patients over subsequent years. Accurate detection of recurrent disease is important because it allows for appropriate treatment selection (e.g., local vs systemic therapy) and early delivery of therapy (e.g., salvage EBRT), which affect patient outcome. In this article, we discuss the paradigm shift in imaging technology in the detection of recurrent prostate cancer. First, we discuss the commonly used morphological and anatomical imaging modalities and their role in the post-RP and post-EBRT settings of BF. Second, we discuss the accuracy of functional and molecular imaging techniques, many of which are under investigation. Further studies are needed to establish the role of imaging techniques for detection of cancer recurrence and clinical decision-making.

Original languageEnglish (US)
Pages (from-to)457-474
Number of pages18
JournalFuture Oncology
Volume10
Issue number3
DOIs
StatePublished - Feb 1 2014

Fingerprint

Molecular Imaging
Prostatic Neoplasms
Radiotherapy
Prostatectomy
Secondary Prevention
Neoplasm Metastasis
Technology
Recurrence
Mortality
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Zaorsky, N., Yamoah, K., Thakur, M. L., Trabulsi, E. J., Showalter, T. N., Hurwitz, M. D., ... Den, R. B. (2014). A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future Oncology, 10(3), 457-474. https://doi.org/10.2217/fon.13.196
Zaorsky, Nicholas ; Yamoah, Kosj ; Thakur, Madhukar L. ; Trabulsi, Edouard J. ; Showalter, Timothy N. ; Hurwitz, Mark D. ; Dicker, Adam P. ; Den, Robert B. / A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. In: Future Oncology. 2014 ; Vol. 10, No. 3. pp. 457-474.
@article{2988ac05cece401e977140fec4b443cc,
title = "A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer",
abstract = "Approximately a third of men with localized prostate cancer who are treated with external beam radiation therapy (EBRT) or radical prostatectomy (RP) develop biochemical failure (BF). Presumably, BF will progress to distant metastasis and prostate cancer-specific mortality in some patients over subsequent years. Accurate detection of recurrent disease is important because it allows for appropriate treatment selection (e.g., local vs systemic therapy) and early delivery of therapy (e.g., salvage EBRT), which affect patient outcome. In this article, we discuss the paradigm shift in imaging technology in the detection of recurrent prostate cancer. First, we discuss the commonly used morphological and anatomical imaging modalities and their role in the post-RP and post-EBRT settings of BF. Second, we discuss the accuracy of functional and molecular imaging techniques, many of which are under investigation. Further studies are needed to establish the role of imaging techniques for detection of cancer recurrence and clinical decision-making.",
author = "Nicholas Zaorsky and Kosj Yamoah and Thakur, {Madhukar L.} and Trabulsi, {Edouard J.} and Showalter, {Timothy N.} and Hurwitz, {Mark D.} and Dicker, {Adam P.} and Den, {Robert B.}",
year = "2014",
month = "2",
day = "1",
doi = "10.2217/fon.13.196",
language = "English (US)",
volume = "10",
pages = "457--474",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "3",

}

Zaorsky, N, Yamoah, K, Thakur, ML, Trabulsi, EJ, Showalter, TN, Hurwitz, MD, Dicker, AP & Den, RB 2014, 'A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer', Future Oncology, vol. 10, no. 3, pp. 457-474. https://doi.org/10.2217/fon.13.196

A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. / Zaorsky, Nicholas; Yamoah, Kosj; Thakur, Madhukar L.; Trabulsi, Edouard J.; Showalter, Timothy N.; Hurwitz, Mark D.; Dicker, Adam P.; Den, Robert B.

In: Future Oncology, Vol. 10, No. 3, 01.02.2014, p. 457-474.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer

AU - Zaorsky, Nicholas

AU - Yamoah, Kosj

AU - Thakur, Madhukar L.

AU - Trabulsi, Edouard J.

AU - Showalter, Timothy N.

AU - Hurwitz, Mark D.

AU - Dicker, Adam P.

AU - Den, Robert B.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Approximately a third of men with localized prostate cancer who are treated with external beam radiation therapy (EBRT) or radical prostatectomy (RP) develop biochemical failure (BF). Presumably, BF will progress to distant metastasis and prostate cancer-specific mortality in some patients over subsequent years. Accurate detection of recurrent disease is important because it allows for appropriate treatment selection (e.g., local vs systemic therapy) and early delivery of therapy (e.g., salvage EBRT), which affect patient outcome. In this article, we discuss the paradigm shift in imaging technology in the detection of recurrent prostate cancer. First, we discuss the commonly used morphological and anatomical imaging modalities and their role in the post-RP and post-EBRT settings of BF. Second, we discuss the accuracy of functional and molecular imaging techniques, many of which are under investigation. Further studies are needed to establish the role of imaging techniques for detection of cancer recurrence and clinical decision-making.

AB - Approximately a third of men with localized prostate cancer who are treated with external beam radiation therapy (EBRT) or radical prostatectomy (RP) develop biochemical failure (BF). Presumably, BF will progress to distant metastasis and prostate cancer-specific mortality in some patients over subsequent years. Accurate detection of recurrent disease is important because it allows for appropriate treatment selection (e.g., local vs systemic therapy) and early delivery of therapy (e.g., salvage EBRT), which affect patient outcome. In this article, we discuss the paradigm shift in imaging technology in the detection of recurrent prostate cancer. First, we discuss the commonly used morphological and anatomical imaging modalities and their role in the post-RP and post-EBRT settings of BF. Second, we discuss the accuracy of functional and molecular imaging techniques, many of which are under investigation. Further studies are needed to establish the role of imaging techniques for detection of cancer recurrence and clinical decision-making.

UR - http://www.scopus.com/inward/record.url?scp=84896806240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896806240&partnerID=8YFLogxK

U2 - 10.2217/fon.13.196

DO - 10.2217/fon.13.196

M3 - Review article

VL - 10

SP - 457

EP - 474

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 3

ER -